Рак молочной железы

Young Breast Cancer Survivor Finds Patient-First Care at Sylvester Comprehensive Cancer Center

Young Breast Cancer Survivor Finds Patient-First Care at Sylvester Comprehensive Cancer Center news.med.miami.edu

В Ростовской области рак молочной железы занимает второе место в структуре онкологической заболеваемости

В Ростовской области рак молочной железы занимает второе место в структуре онкологической заболеваемости znamenka.info

В Ростовской области у 1416 женщин за год выявили рак молочной железы

В Ростовской области у 1416 женщин за год выявили рак молочной железы Районные вести

Research into rare breast cancer type highlights importance of personalised treatment

Research into rare breast cancer type highlights importance of personalised treatment The Institute of Cancer Research

У 43-летней женщины был обнаружен рак молочной железы на ранней стадии, что было выявлено по симптомам, которые многие вьетнамские женщины игнорируют.

У 43-летней женщины был обнаружен рак молочной железы на ранней стадии, что было выявлено по симптомам, которые многие вьетнамские женщины игнорируют. Vietnam.vn

Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns - News-Medical

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns News-Medical

Lombardi Women Marks 20 Years; Honors Real Estate Entrepreneur and Breast Cancer Survivor Jessica Miller on Oct. 1

Lombardi Women Marks 20 Years; Honors Real Estate Entrepreneur and Breast Cancer Survivor Jessica Miller on Oct. 1 The Georgetowner

Phase III Trial Compares HER2-Directed Antibody-Drug Conjugates in Advanced Breast Cancer

Phase III Trial Compares HER2-Directed Antibody-Drug Conjugates in Advanced Breast Cancer The ASCO Post

Chinese Medical Journal evaluates triple regimen for HR+/HER2− advanced breast cancer

Chinese Medical Journal evaluates triple regimen for HR+/HER2− advanced breast cancer EurekAlert! Science News Releases

U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer

U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer BioSpace

Chemotherapy hair loss distress higher in young, Black women

Black women with breast cancer were more likely to experience distress from chemotherapy-induced hair loss at younger ages compared with older women, according to a pilot study published in the Journal of the American Academy of Dermatology. “Chemotherapy-induced alopecia affects the majority of patients receiving…

Novartis, Eli Lilly Oppose Bid to Lower Breast Cancer Drug Prices in India

Novartis, Eli Lilly Oppose Bid to Lower Breast Cancer Drug Prices in India NAVLIN DAILY

Evaluating chemotherapy benefit in high-risk early-stage breast cancer - healthcare-in-europe.com

Evaluating chemotherapy benefit in high-risk early-stage breast cancer healthcare-in-europe.com

Icro Meattini: The Future of Breast Cancer Research Takes Shape Through Young ECI Voices

Icro Meattini: The Future of Breast Cancer Research Takes Shape Through Young ECI Voices Oncodaily